c-Met inhibitor - Wikipedia
IJMS | Free Full-Text | HGF/c-MET Signaling in Melanocytes and Melanoma
c-Met Monoclonal Antibody (3D4) (37-0100)
MET targeting: time for a rematch | Oncogene
Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α - ScienceDirect
Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
c-Met as a potential therapeutic target in triple negative breast cancer - ScienceDirect
C-Met - Wikipedia
c-MET
Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer | Full Text
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors | ACS Medicinal Chemistry Letters
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities | Molecular Cancer | Full Text
Products Archive - Met One Instruments
BMS-794833 | 99.84%(HPLC) | In Stock | c-Met inhibitor
c-Met Monoclonal Antibody (3D4) (37-0100)
Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer | Full Text
Frontiers | c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance
Kimono Style: The John C. Weber Collection - The Metropolitan Museum of Art
Frontiers | Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
c-Met Archives - Network of Cancer Research
Artificial human Met agonists based on macrocycle scaffolds | Nature Communications
